SCHEMBL5449673

SCHEMBL5449673

O=C(Cc1ccc(-c2csc(NCc3ccccc3)n2)s1)NO

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 4/20 0.76
▸ HDAC1 Q13547 3/20 0.67
▸ ALDH1A1 P00352 8/20 0.51
▸ MAPT P10636 7/20 0.51
▸ LMNA P02545 5/20 0.51
▸ MEN1 O00255 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ GAA P10253 4/20 0.51
▸ PKM P14618 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ HPGD P15428 3/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ HTT P42858 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ KDM4E B2RXH2 3/20 0.48
▸ TP53 P04637 1/20 0.48
▸ ELOVL1 Q9BW60 1/20 0.46
▸ TDP1 Q9NUW8 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4430271 0.86 HDAC8 (1.00) HDAC8HDAC1MAPTLMNAMEN1
SCHEMBL4424199 0.85 HDAC8 (0.56) HDAC8HDAC1ALDH1A1MAPTLMNA
SCHEMBL4433721 0.83 HDAC1 (0.59) HDAC8HDAC1ALDH1A1MAPTLMNA
SCHEMBL4420252 0.80 HDAC8 (0.67) HDAC8HDAC1ALDH1A1MAPTMEN1
SCHEMBL4418908 0.79 HDAC8 (0.71) HDAC8HDAC1ALDH1A1MAPTLMNA
SCHEMBL4424449 0.76 HSD17B10 (0.61) HDAC8HDAC1ALDH1A1MAPTLMNA
SCHEMBL4425946 0.73 HDAC8 (0.58) HDAC8HDAC1ALDH1A1MAPTLMNA
SCHEMBL4425057 0.73 HDAC8 (0.77) HDAC8HDAC1ALDH1A1MAPTLMNA
SCHEMBL4424077 0.72 HDAC8 (0.76) HDAC8HDAC1LMNAMEN1KMT2A
SCHEMBL1820346 0.72 ALDH1A1 (0.76) HDAC8HDAC1ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 — — US disclosed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 — — US disclosed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications HDAC1, HDAC11, HDAC2 HDAC8 9/4885HDAC1 1/4885ALDH1A1 447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback